Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
β
-47.49%
Shrank
β
+52.62%
Grew
β
1 Year
Scoreβ
Net Growth-47.49%
Net TrendShrank
Net Income Consistencyβ
Rev Growth+52.62%
Rev TrendGrew
Revenue Consistencyβ
All Time
β
-169.72%
Never
β
+441.35%
Every year
β
All Time
Scoreβ
Net Growth-169.72%
Net TrendNever
Net Income Consistencyβ
Rev Growth+441.35%
Rev TrendEvery year
Revenue Consistencyβ
Explore the 2021 public Archive ranking β
Where CG Oncology, Inc. Common stock has ranked, year by year
Measure
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CGON does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-11-20 | $ 79.47 | β |
1 Year2025-11-20 | $ 40.71 | +95.21% |
All Time2024-01-25 | $ 37.17 | +113.80% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
- Revenue
- Net Income
- Cash
| Year | |||
|---|---|---|---|
| TTM | $ 6M | -$ 237M | $ 984M |
| 2025 | $ 4M | -$ 160M | $ 742M |
| IPO2024 | $ 1M | -$ 88M | $ 741M |
Membership
Explore CGON with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,184 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio





